April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Optimization Of in vitro Conditions Of TGFβ And PDGF Modulation Of V+A+D+ Myofibroblast Development From Precursor Cells
Author Affiliations & Notes
  • Vivek Singh
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Flavia L. Barbosa
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Vandana Agrawal
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Steven E. Wilson
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Vivek Singh, None; Flavia L. Barbosa, None; Vandana Agrawal, None; Steven E. Wilson, None
  • Footnotes
    Support  Supported by EY10056 and EY15638 from National Eye Institute, National Institutes of Health, Bethesda, Maryland and Research to Prevent Blindness, New York, NY.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2012. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vivek Singh, Flavia L. Barbosa, Vandana Agrawal, Steven E. Wilson; Optimization Of in vitro Conditions Of TGFβ And PDGF Modulation Of V+A+D+ Myofibroblast Development From Precursor Cells. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2012.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To test the hypotheses that: (a) development of mature vimentin+/alpha-smoothmuscle actin+/desmin+ (V+A+D+) myofibroblasts from corneal stromalor bone marrow-derived precursor cells are regulated by thecoordinated, sequential action of TGFβ and PDGF; (b) myofibroblastdevelopment in vitro follows a similar developmental pathwayof marker expression as it does in vivo.

 
Methods:
 

Corneal keratocyte was isolated as per Yoshida et.al. (2005)protocol from the fresh eyes of swiss Webster mice (Pel freeze).The corneal fibroblast finally obtained was cultured in serumfree media ( augmented DMEM/F12) or low serum RSF media at differentdoses of TGFβ (0.1 to 2.0 ng/mL) with and w/o mice PDGF(2.0ng/mL) to determine optimal doses and time that promotetransition of the mouse corneal fibroblast to V+A+D+ myofibroblasts.At each time point (2 to 15 days), with each growth factor concentration,we determined the mean % of vimentin+, SMA+ and desmin+ cells(all from single IHC).

 
Results:
 

See Fig 1 & 2

 
Conclusions:
 

We have established the optimal concentration and time requiredto convert the corneal fibroblast to myofibroblast (V+A-D- toV+A+D- to V+A+D+).Our results suggest that dose of 0.5ng/mland 1.0ng/mL of TGFβ along with 2.0ng/mL PDGF in DMEM/F12serum free media are the optimal concentrations to study theabove transformation in sequential manner to V+A+D+ myofibroblast( Fig-1 & 2). The present results will help in better understandingof the biology of myofibroblast development and will lead toprevent haze after PTK and other surface ablation procedures,perhaps through the modulation of cytokine effects on the myofibroblaststhat underlie haze.  

 

 
Keywords: cornea: stroma and keratocytes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×